A retrospective study to assess the effect of fingolimod on the evolution of acute gadolinium-enhancing (Gd+) brain lesions to chronic black holes in patients with Multiple sclerosis.
Phase of Trial: Phase IV
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 17 Mar 2017 New trial record